Leidos Holdings에 대한 매도 수량은 투자자에게 Leidos Holdings의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Leidos Holdings (NYSE:LDOS) 주식, 공매도 수량 보고

Leidos Holdings

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in three reportable segments; Defense Solutions, Civil, and Health. Defense Solutions provides technologically latest services, solutions, and products to a broad customer base. It generates key revenue from Defense Solutions.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Large Cap

Bonds

Broad U.S. Equity ETFs

Specialty ETFs

Commodities

Currency ETFs

Treasuries

Economics

Federal Reserve

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

FSLR

LDOS

SMCI

PowerShares DB US Dollar Index Bullish Fund

WYNN

목요일(14일) 제롬 파월 연방준비제도 의장의 예상치 못한 매파적 발언이 시장을 뒤흔들었다. 미국 주요 주가지수는 하락세로 마감했고 달러는 5일 연속으로 급등했다.
파월 의장은 댈러스 비즈니스 리더들을 대상으로 한 연설에서 미국 경제의 놀라운 강점을 강조하며 연준이 &#34;금리인하를 서두를 필요가 없다&#34;고 말했다.

시장 뒤흔든 파월 연준 의장의 매파적 발언: 주가 하락, 달러 급등, 비트코인 하락

Leidos Holdings Inc

Federal Reserve Chair Jerome Powell's unexpectedly hawkish remarks on Thursday sent markets into a tailspin. Major U.S. equity indices closed in the red, and the dollar soared for <a href="https://www.benzinga.com/topic/interest-rates">a fifth consecutive session</a>.
In a speech to Dallas business leaders, Powell highlighted the remarkable strength of the U.S. economy, indicating that there's no need for the Fed to &#8220;be in a hurry to lower rates.&#8221;
He reiterated the central bank's commitment to reaching its 2% inflation target, stressing the need for careful decision-making as inflation remains above desired levels.
He highlighted productivity gains, which he said have &#8220;grown faster over the past five years than at any point in the two decades preceding the pandemic,&#8221; positioning the U.S. economy as &#8220;the best-performing among major economies.&#8221;
Addressing the October <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41971830/producer-inflation-rises-more-than-expected-in-october-should-traders-rethink-interest-rate-cut-path">producer price index (PPI) uptick</a>, Powell labeled it &#8220;more than an upward bump&#8221; but maintained confidence in the trajectory toward the 2% inflation goal.
<h3 class="wp-block-heading">Markets Reassess Interest Rate Path: Traders Are Less Confident On A December Cut</h3>
Powell&#8217;s comments impacted the interest-rate market, with fed futures now reflecting a reduced likelihood of a 25-basis-point cut in December. 
The CME FedWatch tool shows the odds of such a move dropped to 58%, sharply down from around 80% earlier in the day.
The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), closed down 0.6%, fully erasing gains from last week&#8217;s rate cut. Energy was the only sector in positive territory, rising 0.4%, while industrials and health care led declines, each down 0.7%.
Top performers in the S&amp;P 500 included Tapestry Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>), Wynn Resorts Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>), and First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), which rose 12.8%, 8.7%, and 7.2%, respectively. Among the laggards were Leidos Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) and Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), down 13.6% and 11.4%, respectively.
Tech stocks, as tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), declined 0.7%, marking a fourth consecutive loss. Blue chips followed by the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) slipped 0.5%, while small caps in the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) underperformed, falling 1.3%.
The dollar continued to attract liquidity, with the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) logging a fifth consecutive gain, reaching levels last seen in late October 2023.
Treasury yields also rose, with the 10-year yield closing at 4.46%. Gold, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), marked its fifth straight loss.
In crypto markets, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was 1.7% lower in the past 24 hours to $88,013 at 5:21 p.m. ET, on track for its worst day in November.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41984852/trumps-red-wave-pushes-emerging-market-stocks-to-2-month-lows-volatility-expected-to-remain-elevated">Trump&#8217;s Red Wave Pushes Emerging Market Stocks To 2-Month Lows: Volatility &#8216;Expected To Remain Elevated&#8217; </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Powell's Hawkish Remarks Shake Markets: Stocks Fall, Dollar Rockets, Bitcoin Dips

WIIM

SAIC

Shares of companies that do business as government contractors are trading lower as President-elect Trump makes federal appointments during his transition period. Investors may evaluate the impact of possible cuts from the "Department of Government Efficiency".

A significant insider transaction involving the exercise of company stock options was reported on November 12, by Surya N Mohapatra, Board Member at Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>), as per the latest SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001336920/000162828024046878//Archives/edgar/data/1336920/000162828024046878/0001628280-24-046878-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday showed that Mohapatra, Board Member at Leidos Holdings, a company in the Industrials sector, just exercised stock options worth 4,070 shares of LDOS stock with an exercise price of $63.08.
As of Tuesday morning, Leidos Holdings shares are up by 0.37%, with a current price of $202.14. This implies that Mohapatra's 4,070 shares have a value of $565,954.
<h3>About Leidos Holdings</h3>
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in three reportable segments; Defense Solutions, Civil, and Health. Defense Solutions provides technologically latest services, solutions, and products to a broad customer base. It generates key revenue from Defense Solutions.
<h3>Understanding the Numbers: Leidos Holdings's Finances</h3>
Revenue Growth: Leidos Holdings displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 6.86%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 18.19%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): Leidos Holdings's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 2.72.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.11.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 22.91 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.7, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 14.94, Leidos Holdings presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001336920">Check Out The Full List Of Leidos Holdings's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Trading Ideas

Surya N Mohapatra Exercises Options, Realizes $565K

Leidos Partners With University Of Edinburgh To Accelerate AI And Data Science Innovations Across Key Sectors

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/11/05/final-trades-comerica-amazon-disney-leidos-holdings-and-dupont.html">Halftime Report Final Trades</a>,&#8221; Rob Sechan of NewEdge Wealth named Comerica Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) as <a href="https://www.benzinga.com/quote/CMA">his final trade</a>.
On Nov. 5, Comerica declared dividends and announced an increase in share repurchase authorization.
Jim Lebenthal of Cerity Partners said he is picking Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) for its all-weather capabilities.
Amazon.com's Amazon Prime Video recently unveiled an X-Ray Recaps feature to help users stay updated on their favorite shows, even after long breaks between episodes. Instead of rewinding or searching for plot summaries, viewers can now access spoiler-free, AI-generated recaps to <a href="https://www.benzinga.com/news/24/11/41739915/amazon-takes-on-netflix-with-new-ai-recaps">refresh their memory quickly.</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC named The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), saying that she believes in America's ability to spend, no matter what's the outcome of U.S. elections.
Walt Disney recently announced the creation of a new group, the Office of Technology Enablement (OTE), dedicated to guiding the company's approach to emerging technologies like artificial intelligence (AI) and extended reality (XR).
Bill Baruch of Blue Line Capital picked Leidos Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>).
On Oct. 29, Leidos reported third-quarter fiscal 2024 revenue growth of 7% year-over-year to $4.19 billion, beating the analyst consensus estimate of $4.07 billion. Demand across all customer segments, especially for managed health services, drove the growth.
Stephanie Link of Hightower Advisors picked DuPont de Nemours, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>), which topped earnings expectations for the latest quarter.
On Nov. 5, the company reported sales growth of 4% year over year to $3.192 billion, missing the consensus of $3.204 billion. Organic sales increased +3% YoY, with a 5% increase in volume offset by a 2% decrease in price.
Price Action:
<ul>
<li>Comerica shares gained 1.4% to close at $63.28 during Tuesday's session.</li>
<li>Amazon shares rose 1.9% to settle at $199.50 during Tuesday's session.</li>
<li>Disney shares gained 0.9% to close at $96.63 on Tuesday.</li>
<li>DuPont shares gained 4.7% to settle at $85.67.</li>
<li>Leidos shares gained 2% to settle at $190.07 on Tuesday.</li>
</ul>
Check This Out:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>
Image: Shutterstock

Long Ideas

Markets

Media

AMZN

Amazon, Disney, DuPont, Leidos And A Financial Stock On CNBC's 'Final Trades'

Analyst Ratings

CNBC Halftime Report Final Trades: Comerica, Amazon.com, The Walt Disney Company, Leidos, DuPont de Nemours

Barclays analyst David Strauss maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Overweight and raises the price target from $165 to $210.

Price Target

Barclays Maintains Overweight on Leidos Holdings, Raises Price Target to $210

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4291591-1&amp;h=4206855963&amp;u=https%3A%2F%2Fwww.leidos.com%2F&amp;a=Leidos">Leidos</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) announced today a new contract to modernize the Organ Procurement and Transplant Network (OPTN), a critical system that delivers vital organ transplant information to patients, donors, and healthcare providers. The contract was awarded by the U.S. Department of Health and Human Services through its Health Resources and Services Administration (HRSA). This multiple-award, indefinite delivery/indefinite quantity contract has a total potential value of $235 million, including a base period of performance of one-year and four one-year option periods.

Contracts

Leidos Awarded $235M Organ Procurement And Transplantation Network Operations Contract

Wells Fargo analyst Matthew Akers maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Overweight and raises the price target from $183 to $230.

Wells Fargo Maintains Overweight on Leidos Holdings, Raises Price Target to $230

Citigroup analyst Jason Gursky maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Buy and raises the price target from $194 to $220.

Citigroup Maintains Buy on Leidos Holdings, Raises Price Target to $220

TD Cowen analyst Cai von Rumohr maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Buy and raises the price target from $175 to $200.

TD Cowen Maintains Buy on Leidos Holdings, Raises Price Target to $200

DELL

CNBC Halftime Report Final Trades: Dell Technologies, Leidos, Pfizer, The Trade Desk

RBC Capital analyst Ken Herbert maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Sector Perform and raises the price target from $145 to $180.

RBC Capital Maintains Sector Perform on Leidos Holdings, Raises Price Target to $180

Truist Securities analyst Tobey Sommer maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Buy and raises the price target from $175 to $205.

Truist Securities Maintains Buy on Leidos Holdings, Raises Price Target to $205

Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $189.12, a high estimate of $228.00, and a low estimate of $165.00. This upward trend is apparent, with the current average reflecting a 9.16% increase from the previous average price target of $173.25.
<img src="https://www.benzinga.com/files/images/story/2024/1730293249_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Leidos Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gavin Parsons</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$228.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Peter Arment</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$218.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Jason Gursky</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$194.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Seth Seifman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$185.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$183.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$175.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Mariana Perez</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>David Strauss</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$160.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Leidos Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Leidos Holdings compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Leidos Holdings's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Leidos Holdings's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LDOS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Leidos Holdings analyst ratings.</a>
<h2>Unveiling the Story Behind Leidos Holdings</h2>
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in three reportable segments; Defense Solutions, Civil, and Health. Defense Solutions provides technologically latest services, solutions, and products to a broad customer base. It generates key revenue from Defense Solutions.
<h3>Leidos Holdings's Economic Impact: An Analysis</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Leidos Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.66% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Leidos Holdings's net margin excels beyond industry benchmarks, reaching 7.79%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Leidos Holdings's ROE stands out, surpassing industry averages. With an impressive ROE of 7.39%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Leidos Holdings's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.5%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.16, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Leidos Holdings Stock

Goldman Sachs analyst Gavin Parsons maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Buy and raises the price target from $205 to $228.

Goldman Sachs Maintains Buy on Leidos Holdings, Raises Price Target to $228

Leidos Secures $93M Contract To Provide Supply Support For U.S. Navy And Marine Corps Weapons Systems Under NAVSUP's TARP Program; Contract Includes One-Year Base With Four One-Year Options And A Six-Month Extension

Baird analyst Peter Arment maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Outperform and raises the price target from $180 to $218.

Baird Maintains Outperform on Leidos Holdings, Raises Price Target to $218

Leidos Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) on Tuesday reported third-quarter fiscal 2024 revenue growth of 7% year-over-year to $4.19 billion, beating the <a href="https://www.benzinga.com/pressreleases/24/10/n41593762/leidos-reports-strong-third-quarter-2024-results-and-raises-full-year-guidance" target="_blank" rel="noopener">analyst consensus estimate of $4.07 billion.</a> Demand across all customer segments, especially for managed health services, drove the growth. 
The defense, aviation, information technology, and biomedical research company's adjusted EPS was $2.93, up 44% year over year, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $2.02</a>.
Adjusted net income was $396 million for the quarter, up 40% year-over-year.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/08/40375565/why-leidos-holdings-shares-are-gaining-today" rel="noreferrer noopener">Leidos Wins $86M Contract to Enhance Geospatial Intelligence Systems for National Security</a>
Adjusted EBITDA was $596 million, up 32% year over year. The margin of 14.2% increased from 11.5% a year ago.&nbsp;
Net bookings totaled $8.1 billion for the quarter, representing a book-to-bill ratio of 1.9.&nbsp;As a result, the backlog at the end of the year was $40.6 billion, of which $9.1 billion was funded.&nbsp;
Leidos held $1.19 billion in cash and equivalents as of Sept. 27.
Outlook:&nbsp;Leidos expects fiscal 2024 revenue of $16.35 billion–$16.45 billion (<a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/40047065/defense-stock-leidos-q2-revenue-surges-8-raises-annual-outlook" rel="noreferrer noopener">prior $16.1 billion–$16.4 billion</a>). The analyst consensus stands&nbsp;at $16.3 billion.
The company expects its fiscal 2024 adjusted EPS of $9.80–$10.00 (prior $8.60–$9.00) versus the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$9.08 consensus</a>.
Leidos Holdings stock gained over 57% year-to-date.
Price Action: LDOS stock is up 8.7% at $184.50 at last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41594941/perfect-corp-q3-earnings-revenue-growth-fueled-by-ai-ar-solutions-record-youcam-subscribers" target="_blank" rel="noreferrer noopener">Perfect Corp Q3 Earnings: Revenue Growth Fueled by AI, AR Solutions &amp; Record YouCam Subscribers</a></li>
</ul>
Photo: JHVEPhoto/Shutterstock.com

Earnings

Guidance

Leidos Q3 Earnings Beat Expectations With Strong Demand In Defense And Health Services, Guidance Raised

Leidos Holdings shares are trading higher after the company reported better-than-expected Q3 EPS and sales and raised its FY24 revenue and EPS guidance.

Comments

Leidos Holdings

매도 수량

Leidos Holdings (NYSE:LDOS) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌